Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 19 2022

Full Issue

Small Pharmacies Had Restocking Issues Amid High Adderall Demand

Nearly two thirds of community pharmacies said they had trouble ordering the drug at the end of July and the start of August, at a time when Bloomberg notes demand is at "all-time highs." Also: more opioid settlements, the revival of an old hair loss medicine, custom gene therapy, and more.

Bloomberg: Hundreds Of Small Pharmacies Report Trouble Stocking Adderall

Nearly two-thirds of community pharmacies had trouble ordering the popular attention-deficit/hyperactivity disorder drug Adderall at the end of July and beginning of August, at a time when demand is at all-time highs. (Swetlitz, 8/18)

In other pharmaceutical news —

The Boston Globe: Endo, 36 States Agree To New $450m Opioid Settlement 

Opioid maker Endo International and its lenders reached a settlement with 36 states in its bankruptcy filings, Rhode Island Attorney General Peter F. Neronha announced Thursday. In all, the plan could provide a total of up to $450 million to participating states. (Gagosz, 8/18)

The New York Times: An Old Medicine Remedies Hair Loss For Pennies A Day, Doctors Say

It is minoxidil, an old and well-known hair-loss treatment drug used in a very different way. Rather than being applied directly to the scalp, it is being prescribed in very low-dose pills. (Kolata, 8/18)

The Boston Globe: Harvard Graduate Spearheads Custom Gene Therapy For Younger Brother

Richard Horgan has waited for this moment for more than three years. Last month, the Food and Drug Administration granted permission for his younger brother Terry, 27, who lives with muscular dystrophy, to receive a first-of-its-kind gene therapy that was tailor-made for his genetic mutation. (Cross, 8/18)

In medical technology news —

The Washington Post: Raymond Damadian, Created First MRI Machine, Dies At 86 

Raymond Damadian, who helped revolutionize medical diagnostics by developing the first magnetic resonance imaging machine and who later became so embittered after the Nobel Prize went to two other pioneers in MRI technology that he took out full-page newspaper ads to denounce the decision, died Aug. 3 at his home in Woodbury, N.Y. He was 86.The death was announced in a statement by Fonar Corp., which Dr. Damadian founded in 1978 after being awarded a patent for the MRI concept of using radio waves from atoms to construct images of soft tissue. No cause was given. (Murphy, 8/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF